Patterns and predictors of Warfarin use in patients with new-onset atrial fibrillation from the FRACTAL registry

American Journal of Cardiology

Volumn 97, Issue 4, 2006, Pages 538-543

  Reynolds, Matthew R ^a   Shah, Jignesh ^a   Essebag, Vidal ^a   Olshansky, Brian ^b   Friedman, Paul A ^c   Hadjis, Tomy ^d   Lemery, Robert ^e   Bahnson, Tristram D ^f   Cannom, David S ^g   Josephson, Mark E ^a   Zimetbaum, Peter ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c MAYO CLINIC   (United States)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ANAMNESIS; ARTICLE; CONGESTIVE HEART FAILURE; DEMOGRAPHY; DRUG MIXTURE; DRUG MONITORING; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RISK FACTORS; WARFARIN;

EID: 31944446445     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.09.086     Document Type: Article

References (17)

1. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, et al, Rate Control Versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840.
2. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, et al, Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833.
3. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies development and validation J Chronic Dis 40 1987 373 383
4. F.E. Munschauer, R.L. Priore, M. Hens, A. Castilone Thomboembolism prophylaxis in chronic atrial fibrillation practice patterns in community and tertiary-care hospitals Stroke 28 1997 72 76
5. A.S. Go, E.M. Hylek, L.H. Borowsky, K.A. Phillips, J.V. Selby, D.E. Singer Warfarin use among ambulatory patients with nonvalvular atrial fibrillation the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study Ann Intern Med 131 1999 927 934
6. C.R. Kerr, J. Boone, S.J. Connolly, P. Dorian, M. Green, G. Klein, D. Newman, R. Sheldon, M. Talajic The Canadian Registry of Atrial Fibrillation a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation Am J Cardiol 82 suppl 1998 82N 85N
7. M.R. Antani, R.J. Beyth, K.E. Covinsky, P.A. Anderson, D.G. Miller, R.D. Cebul, L.M. Quinn, C.S. Landefeld Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation J Gen Intern Med 11 1996 713 720
8. V. Fuster, L.E. Ryden, R.W. Asinger, D.S. Cannom, H.J. Crijns, R.L. Frye, J.L. Halperin, G.N. Kay, W.W. Klein, S. Levy ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences Circulation 104 2001 2118 2150
9. P.A. Wolf, R.D. Abbott, W.B. Kannel Atrial fibrillation as an independent risk factor for stroke the Framingham Study Stroke 22 1991 983 988
10. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Arch Intern Med 154 1994 1449 1457
11. D.G. Sherman, L. Goldman, R.B. Whiting, K. Jurgensen, M. Kaste, J.D. Easton Thromboembolism in patients with atrial fibrillation Arch Neurology 41 1984 708 710
12. Stroke Prevention in Atrial Fibrillation Investigators Stroke Prevention in Atrial Fibrillation Study. Final results Circulation 84 1991 527 539
13. A. Laupacis, G. Albers, J. Dalen, M.I. Dunn, A.K. Jacobson, D.E. Singer Antithrombotic therapy in atrial fibrillation Chest 114 suppl 1998 579S 589S
14. D.E. Singer, G.W. Albers, J.E. Dalen, A.S. Go, J.L. Halperin, W.J. Manning Antithrombotic therapy in atrial fibrillation the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 429S 456S
15. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
16. K.H. Humphries, C.R. Kerr, S.J. Connolly, G. Klein, J.A. Boone, M. Green, R. Sheldon, M. Talajic, P. Dorian, D. Newman New onset atrial fibrillation sex differences in presentation, treatment, and outcome Circulation 103 2001 2365 2370
17. R.L. Page, W.E. Wilkinson, W.K. Clair, E.A. McCarthy, E.L.C. Pritchett Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal atrial flutter Circulation 89 1994 224 227